Medicine
Brilinta 90 mg tablet
Brilinta 90 mg tablet is a prescription medicine containing Ticagrelor for oral use, marketed by AstraZeneca Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 86°F).
Key facts
- Active ingredient (INN)
- Ticagrelor
- Brand
- Brilinta
- Strength
- 90 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 10 blister pack, 60 tablets, 5400 tablets and 2 more
- Marketing authorisation holder
- AstraZeneca Pharmaceuticals
- Manufacturers
- AstraZeneca PharmaceuticalsCardinal HealthAphena Pharma Solutions - Tennessee
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC24 Ticagrelor
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2011
- Identifiers
- RxCUI 1116635, 1116639, 1666332 +1DailyMed set ID 1547e2b6-8858-178e-e063-6394a90abb23, f7b3f443-e83d-4bf2-0e96-023448fed9a8, 4f9bd52a-99a7-4606-92b4-456a917aabefNDC 71610-815, 0186-0777, 55154-9618Application NDA022433
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 box, unit-dose / 10 tablet in 1 blister pack | 0186-0777-39 | AstraZeneca Pharmaceuticals | 5 August 2011 |
| 60 tablet in 1 bottle | 0186-0777-60 | AstraZeneca Pharmaceuticals | 5 August 2011 |
| 5400 tablet in 1 bottle | 71610-815-41 | Aphena Pharma Solutions - Tennessee | 3 April 2024 |
| 10 blister pack in 1 bag / 1 tablet in 1 blister pack | 55154-9618-0 | Cardinal Health | 5 August 2011 |
| 1440 tablet in 1 bottle, plastic | 55154-9618-8 | Cardinal Health | 5 August 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ticagrelor 90 mg tablet.
Other strengths and forms of Ticagrelor
Clinical summary
Ticagrelor is a P2Y12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Ticagrelor for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TicagrelorFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BRILINTA prescribing information (AstraZeneca Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Brilique: European public assessment report (EPAR) · European Medicines Agency
Need Brilinta 90 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.